Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tasiken Baheti"'
Autor:
Qing Li, Liren Zhang, Wenhua You, Jiali Xu, Jingjing Dai, Dongxu Hua, Ruizhi Zhang, Feifan Yao, Suiqing Zhou, Wei Huang, Yongjiu Dai, Yu Zhang, Tasiken Baheti, Xiaofeng Qian, Liyong Pu, Jing Xu, Yongxiang Xia, Chuanyong Zhang, Jinhai Tang, Xuehao Wang
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Members of the PRDI-BF1 and RIZ homology domain (PRDM) family have been involved in the regulation of several pathological conditions, including cancer. Here the authors show that PRDM1/BLIMP1 promotes immune evasion by regulating PD-L1 expression in
Externí odkaz:
https://doaj.org/article/fb2dd84c298849c9b30b8a103d084836
Autor:
Tasiken Baheti, Ru-Lin Miao, Gang Zhao, Da-Guang Wang, Feng-Lin Liu, Jiang Yu, Shuang-Yi Ren, Kai Ye, Su Yan, Kun Yang, Wei-Dong Zang, Lin Fan, Bin Liang, Jun Cai, Wei-Hua Fu, Wei Wang, Zheng-Rong Li, Zhao-Jian Niu, Jun You, Xing-Feng Qiu, Wu Song, Lu Zang, Qiang Shi
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 22, Pp 2759-2761 (2020)
Externí odkaz:
https://doaj.org/article/f671fa72c94949b9beec0b86cd940234
Autor:
Qing Li, Liren Zhang, Wenhua You, Jiali Xu, Jingjing Dai, Dongxu Hua, Ruizhi Zhang, Feifan Yao, Suiqing Zhou, Wei Huang, Yongjiu Dai, Yu Zhang, Tasiken Baheti, Xiaofeng Qian, Liyong Pu, Jing Xu, Yongxiang Xia, Chuanyong Zhang, Jinhai Tang, Xuehao Wang
Publikováno v:
Nature communications. 13(1)
Programmed death receptor-1 (PD-1) blockade have achieved some efficacy but only in a fraction of patients with hepatocellular carcinoma (HCC). Programmed cell death 1 ligand 1 (PD-L1) binds to its receptor PD1 on T cells to dampen antigen-tumor immu